 David Riches
Concepts (608)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages | 57 | 2018 | 1547 | 3.060 |
Why?
| | Idiopathic Pulmonary Fibrosis | 12 | 2025 | 657 | 2.610 |
Why?
| | Pulmonary Fibrosis | 17 | 2025 | 402 | 2.420 |
Why?
| | Lung | 29 | 2025 | 4060 | 2.140 |
Why?
| | Tumor Necrosis Factor-alpha | 34 | 2014 | 1242 | 2.110 |
Why?
| | Receptors, Tumor Necrosis Factor | 13 | 2005 | 164 | 1.970 |
Why?
| | Bleomycin | 14 | 2021 | 248 | 1.650 |
Why?
| | Apoptosis | 20 | 2023 | 2553 | 1.530 |
Why?
| | fas Receptor | 7 | 2020 | 95 | 1.410 |
Why?
| | Antigens, CD | 12 | 2004 | 521 | 1.360 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 14 | 2010 | 87 | 1.350 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 11 | 2005 | 185 | 1.210 |
Why?
| | Arthritis, Experimental | 3 | 2018 | 147 | 1.190 |
Why?
| | Fibroblasts | 15 | 2025 | 996 | 1.190 |
Why?
| | Signal Transduction | 27 | 2020 | 5079 | 1.180 |
Why?
| | Macrophages, Alveolar | 10 | 2014 | 391 | 1.110 |
Why?
| | Insulin-Like Growth Factor I | 10 | 2009 | 319 | 1.090 |
Why?
| | Mice | 84 | 2024 | 17787 | 1.050 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 9 | 1999 | 182 | 1.000 |
Why?
| | Mitogen-Activated Protein Kinases | 12 | 2004 | 313 | 0.980 |
Why?
| | Nitric Oxide Synthase | 6 | 2001 | 240 | 0.900 |
Why?
| | Animals | 97 | 2025 | 36940 | 0.890 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 10 | 2002 | 134 | 0.890 |
Why?
| | Alveolar Epithelial Cells | 6 | 2025 | 114 | 0.850 |
Why?
| | Mice, Inbred C3H | 30 | 2005 | 269 | 0.820 |
Why?
| | Trans-Activators | 4 | 2015 | 398 | 0.810 |
Why?
| | Lung Injury | 3 | 2019 | 219 | 0.790 |
Why?
| | Interferon-gamma | 14 | 2010 | 789 | 0.760 |
Why?
| | Collagen | 6 | 2018 | 452 | 0.740 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 11 | 2011 | 162 | 0.710 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 2 | 2018 | 8 | 0.710 |
Why?
| | Epithelial Cells | 9 | 2023 | 1096 | 0.700 |
Why?
| | Pulmonary Emphysema | 1 | 2024 | 288 | 0.700 |
Why?
| | TRPC Cation Channels | 2 | 2010 | 14 | 0.690 |
Why?
| | Immunity, Innate | 4 | 2018 | 828 | 0.680 |
Why?
| | Cells, Cultured | 29 | 2020 | 4193 | 0.630 |
Why?
| | Indoles | 2 | 2019 | 412 | 0.580 |
Why?
| | Macrophage Activation | 11 | 2009 | 201 | 0.580 |
Why?
| | NF-kappa B | 7 | 2009 | 691 | 0.570 |
Why?
| | Pneumonia | 6 | 2018 | 639 | 0.570 |
Why?
| | Myofibroblasts | 1 | 2018 | 127 | 0.540 |
Why?
| | MAP Kinase Kinase 4 | 5 | 2002 | 29 | 0.530 |
Why?
| | Interleukin-4 | 4 | 2008 | 216 | 0.510 |
Why?
| | Lung Diseases, Interstitial | 4 | 2023 | 638 | 0.510 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2024 | 1040 | 0.500 |
Why?
| | Cell Line | 16 | 2019 | 2847 | 0.490 |
Why?
| | Lipopolysaccharides | 9 | 2012 | 886 | 0.480 |
Why?
| | Transforming Growth Factor beta | 9 | 2020 | 480 | 0.480 |
Why?
| | Mice, Knockout | 14 | 2020 | 3015 | 0.470 |
Why?
| | Mice, Inbred C57BL | 20 | 2021 | 5757 | 0.460 |
Why?
| | Serum Response Factor | 1 | 2015 | 33 | 0.460 |
Why?
| | TNF Receptor-Associated Factor 2 | 4 | 2010 | 8 | 0.460 |
Why?
| | Monocytes | 7 | 2018 | 563 | 0.450 |
Why?
| | Protein-Tyrosine Kinases | 6 | 1999 | 434 | 0.440 |
Why?
| | Mesoderm | 1 | 2015 | 144 | 0.430 |
Why?
| | Sodium Chloride | 2 | 2006 | 142 | 0.420 |
Why?
| | Interleukin-8 | 6 | 2009 | 268 | 0.420 |
Why?
| | Arthritis, Rheumatoid | 2 | 2013 | 1167 | 0.410 |
Why?
| | Acute Lung Injury | 2 | 2017 | 287 | 0.400 |
Why?
| | Phosphorylation | 16 | 2020 | 1759 | 0.390 |
Why?
| | Bone Marrow Cells | 10 | 2012 | 316 | 0.380 |
Why?
| | Dendritic Cells | 3 | 2013 | 483 | 0.380 |
Why?
| | Neutrophils | 9 | 2018 | 1238 | 0.370 |
Why?
| | Disease Models, Animal | 7 | 2020 | 4295 | 0.370 |
Why?
| | CASP8 and FADD-Like Apoptosis Regulating Protein | 2 | 2009 | 22 | 0.350 |
Why?
| | Receptor, Muscarinic M1 | 1 | 2010 | 3 | 0.350 |
Why?
| | Lung Diseases | 4 | 2013 | 767 | 0.350 |
Why?
| | beta-Glucans | 5 | 1993 | 20 | 0.340 |
Why?
| | Up-Regulation | 4 | 2012 | 843 | 0.340 |
Why?
| | Adaptive Immunity | 1 | 2011 | 165 | 0.330 |
Why?
| | Nitric Oxide | 5 | 2010 | 915 | 0.320 |
Why?
| | Phagocytosis | 8 | 2012 | 380 | 0.320 |
Why?
| | Enzyme Activation | 13 | 2011 | 810 | 0.320 |
Why?
| | X-Ray Microtomography | 2 | 2021 | 94 | 0.320 |
Why?
| | RNA, Messenger | 18 | 2011 | 2833 | 0.320 |
Why?
| | Humans | 63 | 2025 | 137585 | 0.310 |
Why?
| | Silicosis | 2 | 2023 | 27 | 0.310 |
Why?
| | Transcription, Genetic | 6 | 2014 | 1457 | 0.310 |
Why?
| | Testosterone | 1 | 2013 | 409 | 0.310 |
Why?
| | Molecular Sequence Data | 12 | 2010 | 2900 | 0.310 |
Why?
| | Calcium | 3 | 2010 | 1199 | 0.310 |
Why?
| | Bronchoalveolar Lavage Fluid | 7 | 2011 | 652 | 0.300 |
Why?
| | Lung Compliance | 3 | 2014 | 49 | 0.290 |
Why?
| | Inflammation Mediators | 4 | 2018 | 513 | 0.290 |
Why?
| | Gene Expression Regulation | 8 | 2010 | 2607 | 0.280 |
Why?
| | Cytokines | 8 | 2018 | 2085 | 0.280 |
Why?
| | Poly I-C | 6 | 1994 | 63 | 0.280 |
Why?
| | Interleukin-13 | 2 | 2010 | 149 | 0.270 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 2 | 2020 | 23 | 0.270 |
Why?
| | MAP Kinase Kinase Kinase 1 | 2 | 1999 | 19 | 0.270 |
Why?
| | Inflammation | 8 | 2024 | 2837 | 0.270 |
Why?
| | Autoimmunity | 1 | 2013 | 908 | 0.270 |
Why?
| | Chemokines | 2 | 2006 | 228 | 0.270 |
Why?
| | Promoter Regions, Genetic | 5 | 2008 | 1250 | 0.270 |
Why?
| | Respiratory Mucosa | 5 | 2025 | 321 | 0.270 |
Why?
| | Transcription Factor AP-1 | 2 | 2006 | 92 | 0.260 |
Why?
| | Lysosomes | 6 | 1993 | 141 | 0.250 |
Why?
| | Pulmonary Alveoli | 4 | 2025 | 405 | 0.250 |
Why?
| | Apoptosis Regulatory Proteins | 2 | 2024 | 188 | 0.250 |
Why?
| | Nitric Oxide Synthase Type II | 7 | 2008 | 173 | 0.250 |
Why?
| | Gene Expression | 5 | 2012 | 1502 | 0.250 |
Why?
| | Membrane Microdomains | 2 | 2004 | 32 | 0.250 |
Why?
| | Th2 Cells | 2 | 2004 | 176 | 0.240 |
Why?
| | Granulomatous Disease, Chronic | 3 | 2010 | 55 | 0.240 |
Why?
| | Enzyme Induction | 8 | 2008 | 90 | 0.240 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 9 | 2012 | 283 | 0.240 |
Why?
| | MAP Kinase Kinase 1 | 6 | 2001 | 75 | 0.230 |
Why?
| | 5' Untranslated Regions | 1 | 2005 | 58 | 0.230 |
Why?
| | Proline | 1 | 2005 | 79 | 0.220 |
Why?
| | Male | 28 | 2024 | 67762 | 0.220 |
Why?
| | Recombinant Proteins | 6 | 2010 | 1353 | 0.220 |
Why?
| | Flow Cytometry | 3 | 2020 | 1178 | 0.220 |
Why?
| | Dual Specificity Phosphatase 1 | 3 | 2012 | 26 | 0.220 |
Why?
| | Keratin-8 | 1 | 2023 | 4 | 0.220 |
Why?
| | Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2003 | 5 | 0.220 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2013 | 430 | 0.210 |
Why?
| | Models, Biological | 3 | 2025 | 1783 | 0.210 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 2 | 2023 | 233 | 0.210 |
Why?
| | Precancerous Conditions | 1 | 2004 | 169 | 0.200 |
Why?
| | Proteins | 5 | 2004 | 1009 | 0.200 |
Why?
| | Transfection | 5 | 2009 | 945 | 0.200 |
Why?
| | Growth Substances | 4 | 2004 | 147 | 0.200 |
Why?
| | Stem Cells | 2 | 2019 | 594 | 0.200 |
Why?
| | I-kappa B Proteins | 2 | 2012 | 81 | 0.200 |
Why?
| | Respiratory System | 1 | 2024 | 157 | 0.200 |
Why?
| | Endoplasmic Reticulum | 4 | 2011 | 265 | 0.190 |
Why?
| | Adenoma | 1 | 2004 | 230 | 0.190 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2025 | 248 | 0.190 |
Why?
| | Female | 25 | 2024 | 73304 | 0.190 |
Why?
| | Complement Factor B | 5 | 1994 | 109 | 0.190 |
Why?
| | Mutagenesis, Site-Directed | 4 | 2010 | 375 | 0.190 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 220 | 0.190 |
Why?
| | Cystic Fibrosis | 4 | 2008 | 1114 | 0.180 |
Why?
| | Gene Expression Profiling | 4 | 2020 | 1774 | 0.180 |
Why?
| | Mitochondrial Proteins | 1 | 2024 | 257 | 0.180 |
Why?
| | COS Cells | 5 | 2005 | 188 | 0.180 |
Why?
| | Base Sequence | 8 | 2009 | 2181 | 0.180 |
Why?
| | Lymph Nodes | 3 | 2013 | 491 | 0.180 |
Why?
| | Biocompatible Materials | 1 | 2025 | 425 | 0.180 |
Why?
| | Amino Acid Sequence | 5 | 2010 | 2139 | 0.180 |
Why?
| | Mice, Inbred BALB C | 6 | 2012 | 1272 | 0.170 |
Why?
| | Receptors, Cell Surface | 5 | 2009 | 385 | 0.170 |
Why?
| | Cell Communication | 2 | 2018 | 315 | 0.170 |
Why?
| | Mice, Mutant Strains | 3 | 2011 | 298 | 0.170 |
Why?
| | Glucans | 6 | 1995 | 24 | 0.170 |
Why?
| | Cell Differentiation | 5 | 2023 | 1991 | 0.170 |
Why?
| | Transcription Factors | 3 | 2011 | 1719 | 0.160 |
Why?
| | Interferon-beta | 4 | 1994 | 92 | 0.160 |
Why?
| | Smoke | 2 | 2011 | 141 | 0.160 |
Why?
| | Reference Values | 2 | 2018 | 816 | 0.160 |
Why?
| | Disease Progression | 3 | 2025 | 2757 | 0.160 |
Why?
| | TNF Receptor-Associated Factor 1 | 4 | 2003 | 8 | 0.160 |
Why?
| | MAP Kinase Signaling System | 3 | 2012 | 320 | 0.160 |
Why?
| | Annexin A4 | 1 | 1999 | 6 | 0.160 |
Why?
| | Fibroblast Growth Factor 10 | 1 | 2019 | 23 | 0.160 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 27 | 0.160 |
Why?
| | Hydrogels | 2 | 2025 | 678 | 0.150 |
Why?
| | Cell Survival | 5 | 2013 | 1120 | 0.150 |
Why?
| | Mice, Transgenic | 4 | 2019 | 2167 | 0.150 |
Why?
| | Phosphatidylserines | 4 | 2008 | 91 | 0.150 |
Why?
| | HeLa Cells | 5 | 2013 | 636 | 0.150 |
Why?
| | Fibrosis | 3 | 2019 | 552 | 0.150 |
Why?
| | Drug Resistance, Microbial | 1 | 2018 | 71 | 0.150 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 78 | 0.150 |
Why?
| | Cell Membrane | 4 | 2010 | 738 | 0.150 |
Why?
| | Down-Regulation | 2 | 2018 | 657 | 0.140 |
Why?
| | Biopsy, Needle | 1 | 2018 | 189 | 0.140 |
Why?
| | Case-Control Studies | 3 | 2018 | 3556 | 0.140 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 313 | 0.140 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2001 | 455 | 0.140 |
Why?
| | Cryptogenic Organizing Pneumonia | 1 | 1997 | 19 | 0.140 |
Why?
| | Mycobacterium tuberculosis | 1 | 2001 | 314 | 0.140 |
Why?
| | Immunohistochemistry | 2 | 2018 | 1738 | 0.140 |
Why?
| | Imaging, Three-Dimensional | 1 | 2021 | 580 | 0.130 |
Why?
| | Extracellular Matrix | 3 | 2019 | 528 | 0.130 |
Why?
| | Sex Characteristics | 2 | 2013 | 762 | 0.130 |
Why?
| | Homeostasis | 1 | 2020 | 621 | 0.130 |
Why?
| | Kinetics | 6 | 2004 | 1670 | 0.130 |
Why?
| | Protein Structure, Tertiary | 3 | 2005 | 861 | 0.130 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 622 | 0.120 |
Why?
| | Nuclear Proteins | 1 | 2001 | 712 | 0.120 |
Why?
| | NADPH Oxidases | 3 | 2010 | 113 | 0.120 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 4 | 2012 | 852 | 0.120 |
Why?
| | Lung Neoplasms | 2 | 2009 | 2526 | 0.120 |
Why?
| | Protein Transport | 4 | 2011 | 445 | 0.120 |
Why?
| | Enzyme Inhibitors | 4 | 2010 | 840 | 0.120 |
Why?
| | Interleukin-10 | 1 | 1997 | 302 | 0.120 |
Why?
| | Electrophoretic Mobility Shift Assay | 2 | 2006 | 86 | 0.120 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 278 | 0.120 |
Why?
| | Permeability | 2 | 2017 | 161 | 0.120 |
Why?
| | Fas Ligand Protein | 2 | 2013 | 60 | 0.120 |
Why?
| | DNA-Binding Proteins | 4 | 2005 | 1502 | 0.120 |
Why?
| | Platelet Activating Factor | 2 | 1995 | 76 | 0.120 |
Why?
| | Blotting, Western | 6 | 2015 | 1226 | 0.110 |
Why?
| | Asbestos | 2 | 1993 | 38 | 0.110 |
Why?
| | Biomarkers | 2 | 2024 | 4149 | 0.110 |
Why?
| | Hyaluronic Acid | 2 | 1994 | 225 | 0.110 |
Why?
| | Receptor, Macrophage Colony-Stimulating Factor | 1 | 2014 | 11 | 0.110 |
Why?
| | Hydroxyproline | 1 | 2014 | 21 | 0.110 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2009 | 329 | 0.110 |
Why?
| | Tacrolimus Binding Proteins | 1 | 2014 | 27 | 0.110 |
Why?
| | Binding Sites | 2 | 2010 | 1303 | 0.110 |
Why?
| | Sequence Deletion | 2 | 2005 | 183 | 0.110 |
Why?
| | Receptors, Immunologic | 2 | 2015 | 216 | 0.110 |
Why?
| | Fas-Associated Death Domain Protein | 2 | 2005 | 9 | 0.110 |
Why?
| | Consensus Sequence | 2 | 2005 | 73 | 0.110 |
Why?
| | Interferons | 2 | 1998 | 202 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2009 | 437 | 0.100 |
Why?
| | Receptors, Lymphocyte Homing | 1 | 1993 | 16 | 0.100 |
Why?
| | Bronchiolitis Obliterans | 1 | 1994 | 69 | 0.100 |
Why?
| | Endocytosis | 2 | 2011 | 172 | 0.100 |
Why?
| | Risk Factors | 3 | 2024 | 10388 | 0.100 |
Why?
| | Proto-Oncogene Proteins | 3 | 2004 | 648 | 0.100 |
Why?
| | Extracellular Vesicles | 1 | 2015 | 146 | 0.100 |
Why?
| | Remission Induction | 1 | 2014 | 288 | 0.100 |
Why?
| | Fibronectins | 1 | 1994 | 133 | 0.100 |
Why?
| | Polymerase Chain Reaction | 5 | 2012 | 1062 | 0.100 |
Why?
| | Proteolysis | 1 | 2013 | 177 | 0.100 |
Why?
| | Chemokine CXCL1 | 2 | 2011 | 76 | 0.100 |
Why?
| | Cytoplasm | 2 | 2005 | 274 | 0.100 |
Why?
| | Drug Synergism | 3 | 2003 | 382 | 0.100 |
Why?
| | Protein Kinase C | 1 | 1994 | 261 | 0.100 |
Why?
| | Anthrax | 1 | 2012 | 10 | 0.100 |
Why?
| | Bacillus anthracis | 1 | 2012 | 13 | 0.100 |
Why?
| | Transcriptional Activation | 2 | 2005 | 378 | 0.090 |
Why?
| | Delayed-Action Preparations | 1 | 2012 | 181 | 0.090 |
Why?
| | Cell Lineage | 1 | 2013 | 350 | 0.090 |
Why?
| | GTPase-Activating Proteins | 1 | 2012 | 83 | 0.090 |
Why?
| | Matrix Metalloproteinase 3 | 1 | 2011 | 28 | 0.090 |
Why?
| | Ventilator-Induced Lung Injury | 1 | 2012 | 59 | 0.090 |
Why?
| | Receptors, Lipoprotein | 1 | 1991 | 6 | 0.090 |
Why?
| | Okadaic Acid | 2 | 2001 | 14 | 0.090 |
Why?
| | Pyridones | 1 | 2012 | 168 | 0.090 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 145 | 0.090 |
Why?
| | Autophagy | 1 | 2013 | 284 | 0.090 |
Why?
| | Trauma Severity Indices | 1 | 2011 | 106 | 0.090 |
Why?
| | Microscopy, Electron | 3 | 2015 | 443 | 0.090 |
Why?
| | Leukotrienes | 1 | 1991 | 37 | 0.090 |
Why?
| | Oxidative Stress | 3 | 2015 | 1317 | 0.090 |
Why?
| | Peritonitis | 2 | 2010 | 84 | 0.090 |
Why?
| | Wound Healing | 2 | 2017 | 331 | 0.090 |
Why?
| | Receptors, IgG | 3 | 2009 | 75 | 0.090 |
Why?
| | Chemokine CXCL2 | 2 | 2010 | 43 | 0.090 |
Why?
| | Orthomyxoviridae Infections | 1 | 2011 | 67 | 0.090 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2011 | 110 | 0.090 |
Why?
| | Cloning, Molecular | 2 | 2003 | 534 | 0.080 |
Why?
| | Schistosoma mansoni | 1 | 2010 | 37 | 0.080 |
Why?
| | Lipoproteins, LDL | 1 | 1991 | 116 | 0.080 |
Why?
| | Antigen Presentation | 1 | 2011 | 218 | 0.080 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 2 | 2004 | 152 | 0.080 |
Why?
| | Schistosomiasis | 1 | 2010 | 47 | 0.080 |
Why?
| | Granuloma | 1 | 2010 | 92 | 0.080 |
Why?
| | Protein Binding | 5 | 2013 | 2224 | 0.080 |
Why?
| | Recovery of Function | 1 | 2014 | 653 | 0.080 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2011 | 148 | 0.080 |
Why?
| | Nitrites | 2 | 2001 | 84 | 0.080 |
Why?
| | Cell Proliferation | 3 | 2017 | 2475 | 0.080 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 350 | 0.080 |
Why?
| | Thiazolidinediones | 1 | 2010 | 137 | 0.080 |
Why?
| | NIH 3T3 Cells | 2 | 2014 | 144 | 0.080 |
Why?
| | Antigens | 1 | 2011 | 357 | 0.080 |
Why?
| | PPAR gamma | 1 | 2010 | 182 | 0.080 |
Why?
| | Elastin | 1 | 2009 | 78 | 0.080 |
Why?
| | Mitochondria | 1 | 2015 | 948 | 0.080 |
Why?
| | MicroRNAs | 1 | 2015 | 692 | 0.080 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2009 | 131 | 0.070 |
Why?
| | Intubation, Intratracheal | 1 | 2011 | 257 | 0.070 |
Why?
| | Mutation | 4 | 2008 | 3958 | 0.070 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2009 | 171 | 0.070 |
Why?
| | Myoblasts | 1 | 2009 | 84 | 0.070 |
Why?
| | Drug Delivery Systems | 1 | 2012 | 365 | 0.070 |
Why?
| | Protein Processing, Post-Translational | 2 | 2005 | 465 | 0.070 |
Why?
| | DEAD-box RNA Helicases | 1 | 2009 | 76 | 0.070 |
Why?
| | Tetradecanoylphorbol Acetate | 2 | 2001 | 150 | 0.070 |
Why?
| | Interleukin-1 | 3 | 2001 | 965 | 0.070 |
Why?
| | Vitamin D | 1 | 2012 | 397 | 0.070 |
Why?
| | Superoxide Dismutase | 1 | 2010 | 346 | 0.070 |
Why?
| | Hypersensitivity | 1 | 2011 | 257 | 0.070 |
Why?
| | Time Factors | 3 | 2014 | 6828 | 0.070 |
Why?
| | Glucocorticoids | 2 | 2012 | 594 | 0.070 |
Why?
| | Gene Amplification | 1 | 2008 | 104 | 0.070 |
Why?
| | Respiration, Artificial | 1 | 2012 | 645 | 0.070 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2008 | 66 | 0.070 |
Why?
| | Prednisone | 1 | 2008 | 240 | 0.070 |
Why?
| | Interleukin-1beta | 1 | 2009 | 372 | 0.070 |
Why?
| | Interferon Type I | 1 | 1988 | 140 | 0.070 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 2 | 1998 | 43 | 0.070 |
Why?
| | Asthma | 2 | 2012 | 2295 | 0.070 |
Why?
| | Genes, Reporter | 2 | 2014 | 269 | 0.070 |
Why?
| | Nanoparticles | 1 | 2012 | 481 | 0.070 |
Why?
| | Anti-Inflammatory Agents | 2 | 2019 | 496 | 0.070 |
Why?
| | Chromatography, Ion Exchange | 2 | 1997 | 55 | 0.070 |
Why?
| | Survival Rate | 1 | 2011 | 1972 | 0.060 |
Why?
| | B-Lymphocytes | 1 | 2012 | 847 | 0.060 |
Why?
| | Middle Aged | 8 | 2012 | 33479 | 0.060 |
Why?
| | Genetic Vectors | 2 | 2011 | 319 | 0.060 |
Why?
| | Vaccines | 1 | 2011 | 406 | 0.060 |
Why?
| | Receptor, ErbB-2 | 1 | 2008 | 341 | 0.060 |
Why?
| | Glucuronidase | 3 | 1993 | 44 | 0.060 |
Why?
| | Adenine Nucleotides | 1 | 1985 | 23 | 0.060 |
Why?
| | Metalloendopeptidases | 1 | 2005 | 62 | 0.060 |
Why?
| | Asparagine | 1 | 2005 | 31 | 0.060 |
Why?
| | Sp3 Transcription Factor | 1 | 2005 | 5 | 0.060 |
Why?
| | Sex Factors | 1 | 2011 | 2071 | 0.060 |
Why?
| | Bronchoalveolar Lavage | 2 | 2012 | 93 | 0.060 |
Why?
| | Bone Marrow | 3 | 2004 | 286 | 0.060 |
Why?
| | Antibodies | 2 | 1998 | 410 | 0.060 |
Why?
| | Golgi Apparatus | 2 | 2005 | 100 | 0.060 |
Why?
| | Luciferases | 1 | 2005 | 150 | 0.060 |
Why?
| | Coculture Techniques | 1 | 2025 | 239 | 0.060 |
Why?
| | Colorado | 1 | 2015 | 4565 | 0.060 |
Why?
| | Serine | 1 | 2005 | 141 | 0.060 |
Why?
| | Dinoprostone | 3 | 1995 | 191 | 0.060 |
Why?
| | Culture Media, Conditioned | 1 | 2004 | 110 | 0.050 |
Why?
| | Membrane Proteins | 1 | 1991 | 1164 | 0.050 |
Why?
| | Hyperplasia | 1 | 2004 | 175 | 0.050 |
Why?
| | Point Mutation | 1 | 2005 | 235 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 2 | 2013 | 665 | 0.050 |
Why?
| | Amino Acid Substitution | 1 | 2005 | 307 | 0.050 |
Why?
| | Antibodies, Monoclonal | 4 | 1999 | 1430 | 0.050 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2004 | 127 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 976 | 0.050 |
Why?
| | rac GTP-Binding Proteins | 1 | 2004 | 32 | 0.050 |
Why?
| | Congresses as Topic | 1 | 2025 | 233 | 0.050 |
Why?
| | CD36 Antigens | 1 | 2004 | 36 | 0.050 |
Why?
| | TNF Receptor-Associated Death Domain Protein | 1 | 2003 | 2 | 0.050 |
Why?
| | Phenotype | 4 | 2019 | 3196 | 0.050 |
Why?
| | Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2003 | 14 | 0.050 |
Why?
| | Actins | 4 | 2009 | 416 | 0.050 |
Why?
| | STAT6 Transcription Factor | 1 | 2003 | 27 | 0.050 |
Why?
| | Longitudinal Studies | 1 | 2011 | 2844 | 0.050 |
Why?
| | Age Factors | 1 | 2011 | 3295 | 0.050 |
Why?
| | Exons | 1 | 2005 | 355 | 0.050 |
Why?
| | Blood Proteins | 2 | 2001 | 252 | 0.050 |
Why?
| | STAT1 Transcription Factor | 1 | 2003 | 72 | 0.050 |
Why?
| | In Vitro Techniques | 3 | 1991 | 1092 | 0.050 |
Why?
| | Platelet-Derived Growth Factor | 2 | 1993 | 93 | 0.050 |
Why?
| | Calcimycin | 2 | 1994 | 49 | 0.050 |
Why?
| | Silicon Dioxide | 1 | 2003 | 115 | 0.050 |
Why?
| | Chromones | 1 | 2002 | 44 | 0.050 |
Why?
| | Thorax | 1 | 2022 | 50 | 0.050 |
Why?
| | Osmotic Pressure | 1 | 2002 | 38 | 0.050 |
Why?
| | Microscopy, Fluorescence | 2 | 2004 | 402 | 0.050 |
Why?
| | Phosphoamino Acids | 1 | 2001 | 1 | 0.050 |
Why?
| | Adenoviridae | 2 | 2014 | 193 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor, Member 25 | 1 | 2001 | 5 | 0.050 |
Why?
| | Flavonoids | 1 | 2002 | 85 | 0.050 |
Why?
| | Beclomethasone | 1 | 2001 | 27 | 0.050 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2001 | 30 | 0.050 |
Why?
| | Morpholines | 1 | 2002 | 122 | 0.050 |
Why?
| | Adrenal Glands | 1 | 2001 | 78 | 0.040 |
Why?
| | MAP Kinase Kinase 7 | 1 | 2001 | 8 | 0.040 |
Why?
| | Jurkat Cells | 2 | 2013 | 134 | 0.040 |
Why?
| | NF-KappaB Inhibitor alpha | 1 | 2001 | 54 | 0.040 |
Why?
| | Genes, bcl-2 | 1 | 2001 | 21 | 0.040 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2009 | 2189 | 0.040 |
Why?
| | Caspase 8 | 1 | 2001 | 48 | 0.040 |
Why?
| | Genes, Dominant | 1 | 2001 | 96 | 0.040 |
Why?
| | Caspase 9 | 1 | 2001 | 57 | 0.040 |
Why?
| | In Situ Nick-End Labeling | 1 | 2001 | 124 | 0.040 |
Why?
| | Rats | 3 | 2017 | 5647 | 0.040 |
Why?
| | Aged | 4 | 2009 | 23961 | 0.040 |
Why?
| | Gene Deletion | 2 | 2014 | 391 | 0.040 |
Why?
| | Prospective Studies | 2 | 2011 | 7604 | 0.040 |
Why?
| | Acetylcysteine | 1 | 2001 | 145 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 1 | 2009 | 2426 | 0.040 |
Why?
| | Polyethylene Glycols | 1 | 2025 | 641 | 0.040 |
Why?
| | Hydrolases | 2 | 1993 | 48 | 0.040 |
Why?
| | Phosphopeptides | 1 | 2000 | 20 | 0.040 |
Why?
| | Peptide Mapping | 1 | 2000 | 64 | 0.040 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2000 | 67 | 0.040 |
Why?
| | Caspases | 1 | 2001 | 247 | 0.040 |
Why?
| | Imidazoles | 1 | 2001 | 238 | 0.040 |
Why?
| | NADPH Oxidase 2 | 2 | 2010 | 39 | 0.040 |
Why?
| | Immunoblotting | 2 | 2001 | 308 | 0.040 |
Why?
| | Protein Phosphatase 2 | 1 | 2000 | 41 | 0.040 |
Why?
| | Molecular Weight | 1 | 2000 | 335 | 0.040 |
Why?
| | Adult | 8 | 2012 | 37929 | 0.040 |
Why?
| | Sepharose | 1 | 1999 | 34 | 0.040 |
Why?
| | Alkaline Phosphatase | 1 | 2000 | 148 | 0.040 |
Why?
| | Nitrobenzoates | 1 | 1998 | 1 | 0.040 |
Why?
| | Obesity | 1 | 2012 | 2992 | 0.040 |
Why?
| | Substrate Specificity | 1 | 2000 | 372 | 0.040 |
Why?
| | Hypertension, Pulmonary | 1 | 2010 | 1910 | 0.040 |
Why?
| | Indomethacin | 2 | 1991 | 81 | 0.040 |
Why?
| | DNA, Complementary | 1 | 1999 | 272 | 0.040 |
Why?
| | 3T3 Cells | 1 | 1999 | 163 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2001 | 558 | 0.040 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 1998 | 61 | 0.040 |
Why?
| | Scleroderma, Systemic | 1 | 2019 | 122 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1999 | 385 | 0.040 |
Why?
| | Dexamethasone | 2 | 2012 | 368 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2012 | 767 | 0.040 |
Why?
| | MAP Kinase Kinase 3 | 1 | 1997 | 7 | 0.040 |
Why?
| | Chemotactic Factors | 1 | 1998 | 56 | 0.040 |
Why?
| | Chemokines, CXC | 1 | 1998 | 70 | 0.040 |
Why?
| | DNA Probes | 1 | 1997 | 60 | 0.030 |
Why?
| | Phospholipids | 1 | 1999 | 223 | 0.030 |
Why?
| | Adaptation, Physiological | 2 | 1995 | 553 | 0.030 |
Why?
| | Drug Interactions | 1 | 1998 | 410 | 0.030 |
Why?
| | Interleukin-6 | 2 | 2008 | 778 | 0.030 |
Why?
| | Pyridines | 1 | 2001 | 506 | 0.030 |
Why?
| | Regeneration | 1 | 2019 | 197 | 0.030 |
Why?
| | Chemokine CXCL12 | 1 | 2017 | 81 | 0.030 |
Why?
| | Reactive Oxygen Species | 2 | 2010 | 622 | 0.030 |
Why?
| | RNA-Binding Proteins | 1 | 2001 | 422 | 0.030 |
Why?
| | Receptors, CXCR4 | 1 | 2017 | 86 | 0.030 |
Why?
| | Cilia | 1 | 1998 | 178 | 0.030 |
Why?
| | Cell Division | 1 | 1998 | 794 | 0.030 |
Why?
| | Catalysis | 1 | 1997 | 307 | 0.030 |
Why?
| | Membrane Glycoproteins | 2 | 2010 | 500 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2001 | 771 | 0.030 |
Why?
| | Blotting, Northern | 2 | 1998 | 201 | 0.030 |
Why?
| | Complement C3 | 2 | 1988 | 209 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 2 | 2012 | 2486 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 1998 | 382 | 0.030 |
Why?
| | Arrestins | 1 | 2015 | 14 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2008 | 2253 | 0.030 |
Why?
| | Receptor Aggregation | 1 | 1995 | 11 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2015 | 32 | 0.030 |
Why?
| | Cell Movement | 2 | 2013 | 967 | 0.030 |
Why?
| | Sequence Analysis, DNA | 2 | 2009 | 812 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 1995 | 45 | 0.030 |
Why?
| | Pancreatic Elastase | 1 | 1995 | 58 | 0.030 |
Why?
| | Lymphocytes | 1 | 1997 | 397 | 0.030 |
Why?
| | Protein Kinases | 1 | 1997 | 319 | 0.030 |
Why?
| | Leukocyte Elastase | 1 | 1995 | 76 | 0.030 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2015 | 99 | 0.030 |
Why?
| | Regression Analysis | 1 | 1997 | 1024 | 0.030 |
Why?
| | Eosinophils | 1 | 1997 | 332 | 0.030 |
Why?
| | Toll-Like Receptors | 1 | 2015 | 185 | 0.030 |
Why?
| | Cell-Derived Microparticles | 1 | 2015 | 71 | 0.030 |
Why?
| | Exosomes | 1 | 2015 | 103 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2017 | 545 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2022 | 2828 | 0.030 |
Why?
| | Leukocyte Count | 1 | 1995 | 329 | 0.030 |
Why?
| | Smad Proteins | 1 | 2014 | 42 | 0.030 |
Why?
| | Sequestosome-1 Protein | 1 | 2013 | 15 | 0.030 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2014 | 59 | 0.030 |
Why?
| | alpha 1-Antitrypsin | 1 | 1995 | 108 | 0.030 |
Why?
| | Forecasting | 1 | 1995 | 389 | 0.030 |
Why?
| | Chloroquine | 1 | 2013 | 54 | 0.030 |
Why?
| | beta-N-Acetylhexosaminidases | 2 | 1991 | 11 | 0.030 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 1995 | 220 | 0.030 |
Why?
| | Antigens, Ly | 1 | 2013 | 44 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2010 | 1316 | 0.030 |
Why?
| | Macrophages, Peritoneal | 1 | 1993 | 94 | 0.030 |
Why?
| | Eicosanoids | 1 | 1993 | 62 | 0.030 |
Why?
| | Culture Media | 1 | 2013 | 165 | 0.030 |
Why?
| | Toll-Like Receptor 4 | 1 | 2015 | 273 | 0.030 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 916 | 0.030 |
Why?
| | Zymosan | 2 | 2010 | 65 | 0.030 |
Why?
| | Polyglactin 910 | 1 | 2012 | 6 | 0.030 |
Why?
| | Endothelium | 1 | 2013 | 123 | 0.030 |
Why?
| | PPAR delta | 1 | 2012 | 5 | 0.030 |
Why?
| | Isoenzymes | 1 | 1994 | 304 | 0.030 |
Why?
| | Receptors, Chemokine | 1 | 2012 | 47 | 0.020 |
Why?
| | Cyclooxygenase 2 | 1 | 2013 | 178 | 0.020 |
Why?
| | Spores, Bacterial | 1 | 2012 | 19 | 0.020 |
Why?
| | Young Adult | 1 | 2009 | 13209 | 0.020 |
Why?
| | Diterpenes | 1 | 2012 | 31 | 0.020 |
Why?
| | Ionomycin | 1 | 1992 | 23 | 0.020 |
Why?
| | Receptors, CCR7 | 1 | 2012 | 32 | 0.020 |
Why?
| | Prone Position | 1 | 2012 | 30 | 0.020 |
Why?
| | Cell Separation | 1 | 1993 | 318 | 0.020 |
Why?
| | Supine Position | 1 | 2012 | 39 | 0.020 |
Why?
| | Berylliosis | 1 | 1994 | 186 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2013 | 390 | 0.020 |
Why?
| | Immunophenotyping | 1 | 1993 | 318 | 0.020 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2009 | 3715 | 0.020 |
Why?
| | Autoradiography | 1 | 1991 | 78 | 0.020 |
Why?
| | Anions | 1 | 1991 | 31 | 0.020 |
Why?
| | Sarcoidosis | 1 | 1994 | 159 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 88 | 0.020 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2013 | 367 | 0.020 |
Why?
| | Caspase 12 | 1 | 2011 | 1 | 0.020 |
Why?
| | Aldehydes | 1 | 2012 | 145 | 0.020 |
Why?
| | Lymphocyte Depletion | 1 | 2012 | 135 | 0.020 |
Why?
| | Thapsigargin | 1 | 2011 | 20 | 0.020 |
Why?
| | Staurosporine | 1 | 2011 | 20 | 0.020 |
Why?
| | Receptors, Complement | 1 | 2012 | 122 | 0.020 |
Why?
| | Adolescent | 2 | 2009 | 21513 | 0.020 |
Why?
| | Instillation, Drug | 1 | 2011 | 10 | 0.020 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2011 | 56 | 0.020 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2012 | 130 | 0.020 |
Why?
| | Cyclin D1 | 1 | 2011 | 68 | 0.020 |
Why?
| | 5,8,11,14-Eicosatetraynoic Acid | 1 | 1991 | 4 | 0.020 |
Why?
| | SRS-A | 1 | 1991 | 31 | 0.020 |
Why?
| | Asbestos, Serpentine | 1 | 1991 | 6 | 0.020 |
Why?
| | Phospholipases A2 | 1 | 1991 | 80 | 0.020 |
Why?
| | Scavenger Receptors, Class B | 1 | 1991 | 14 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 1991 | 409 | 0.020 |
Why?
| | Receptors, Glucocorticoid | 1 | 2012 | 155 | 0.020 |
Why?
| | Receptors, Scavenger | 1 | 1991 | 23 | 0.020 |
Why?
| | Lipoxygenase Inhibitors | 1 | 1991 | 37 | 0.020 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2011 | 132 | 0.020 |
Why?
| | Calcium Channel Blockers | 1 | 1992 | 167 | 0.020 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 1991 | 79 | 0.020 |
Why?
| | Cell Fractionation | 1 | 1990 | 56 | 0.020 |
Why?
| | Onium Compounds | 1 | 2010 | 9 | 0.020 |
Why?
| | Cell Compartmentation | 1 | 1990 | 52 | 0.020 |
Why?
| | Phospholipases A | 1 | 1991 | 102 | 0.020 |
Why?
| | Subcellular Fractions | 1 | 1990 | 82 | 0.020 |
Why?
| | Benzoquinones | 1 | 1991 | 48 | 0.020 |
Why?
| | Phagosomes | 1 | 1990 | 44 | 0.020 |
Why?
| | Sputum | 1 | 2012 | 311 | 0.020 |
Why?
| | Intracellular Membranes | 1 | 1990 | 84 | 0.020 |
Why?
| | Immunoglobulin M | 1 | 2012 | 289 | 0.020 |
Why?
| | Smad3 Protein | 1 | 2010 | 43 | 0.020 |
Why?
| | Smad2 Protein | 1 | 2010 | 38 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2011 | 283 | 0.020 |
Why?
| | Endomyocardial Fibrosis | 1 | 2009 | 3 | 0.020 |
Why?
| | Cadherins | 1 | 2011 | 206 | 0.020 |
Why?
| | Janus Kinase 2 | 1 | 2009 | 32 | 0.020 |
Why?
| | Ventricular Pressure | 1 | 2009 | 48 | 0.020 |
Why?
| | Stress Fibers | 1 | 2009 | 19 | 0.020 |
Why?
| | Amiloride | 1 | 2009 | 26 | 0.020 |
Why?
| | STAT5 Transcription Factor | 1 | 2009 | 57 | 0.020 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2011 | 209 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2001 | 2057 | 0.020 |
Why?
| | Immunoenzyme Techniques | 1 | 2009 | 219 | 0.020 |
Why?
| | Viral Load | 1 | 2011 | 466 | 0.020 |
Why?
| | Survivors | 1 | 2013 | 493 | 0.020 |
Why?
| | beta Catenin | 1 | 2011 | 253 | 0.020 |
Why?
| | Interferon-Induced Helicase, IFIH1 | 1 | 2009 | 19 | 0.020 |
Why?
| | RNA Splice Sites | 1 | 2009 | 45 | 0.020 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2009 | 86 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2009 | 390 | 0.020 |
Why?
| | Codon, Nonsense | 1 | 2009 | 44 | 0.020 |
Why?
| | Receptors, Interleukin-1 | 1 | 2009 | 216 | 0.020 |
Why?
| | Skin | 1 | 2013 | 752 | 0.020 |
Why?
| | Immune Sera | 1 | 1988 | 88 | 0.020 |
Why?
| | Neutralization Tests | 1 | 1988 | 75 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2009 | 268 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2008 | 155 | 0.020 |
Why?
| | Drug Resistance | 1 | 2008 | 169 | 0.020 |
Why?
| | DNA, Neoplasm | 1 | 2008 | 164 | 0.020 |
Why?
| | Open Reading Frames | 1 | 2008 | 123 | 0.020 |
Why?
| | Gene Frequency | 1 | 2009 | 521 | 0.020 |
Why?
| | Stress, Mechanical | 1 | 2009 | 485 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2008 | 399 | 0.020 |
Why?
| | Acid Phosphatase | 1 | 1986 | 20 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2008 | 955 | 0.020 |
Why?
| | Hexosaminidases | 1 | 1986 | 18 | 0.020 |
Why?
| | Risk | 1 | 2009 | 912 | 0.020 |
Why?
| | Methylamines | 1 | 1986 | 34 | 0.020 |
Why?
| | COP-Coated Vesicles | 1 | 2005 | 2 | 0.020 |
Why?
| | Chemotaxis, Leukocyte | 1 | 1986 | 136 | 0.010 |
Why?
| | Tubercidin | 1 | 1985 | 2 | 0.010 |
Why?
| | Secretory Rate | 1 | 1985 | 16 | 0.010 |
Why?
| | Esterases | 1 | 1985 | 14 | 0.010 |
Why?
| | ADAM17 Protein | 1 | 2005 | 35 | 0.010 |
Why?
| | Threonine | 1 | 2005 | 47 | 0.010 |
Why?
| | Receptors, Purinergic | 1 | 1985 | 22 | 0.010 |
Why?
| | ADAM Proteins | 1 | 2005 | 61 | 0.010 |
Why?
| | Theophylline | 1 | 1985 | 67 | 0.010 |
Why?
| | Myocytes, Cardiac | 1 | 2009 | 526 | 0.010 |
Why?
| | Homocysteine | 1 | 1985 | 156 | 0.010 |
Why?
| | T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 1 | 2004 | 3 | 0.010 |
Why?
| | Guanine Nucleotides | 1 | 2004 | 14 | 0.010 |
Why?
| | Cell Surface Extensions | 1 | 2004 | 13 | 0.010 |
Why?
| | Structure-Activity Relationship | 1 | 1985 | 570 | 0.010 |
Why?
| | Cell Size | 1 | 2004 | 91 | 0.010 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2004 | 56 | 0.010 |
Why?
| | Erythrocytes | 1 | 2009 | 700 | 0.010 |
Why?
| | Genetic Variation | 1 | 2009 | 991 | 0.010 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2004 | 66 | 0.010 |
Why?
| | Adenosine | 1 | 1985 | 225 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 1986 | 433 | 0.010 |
Why?
| | Infant, Newborn | 1 | 1995 | 6079 | 0.010 |
Why?
| | Adenine | 1 | 1985 | 271 | 0.010 |
Why?
| | Cytoskeleton | 1 | 2004 | 191 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 1396 | 0.010 |
Why?
| | Genome-Wide Association Study | 1 | 2009 | 1431 | 0.010 |
Why?
| | Cohort Studies | 1 | 2012 | 5742 | 0.010 |
Why?
| | Airway Resistance | 1 | 2001 | 41 | 0.010 |
Why?
| | Nebulizers and Vaporizers | 1 | 2001 | 86 | 0.010 |
Why?
| | Microtubules | 1 | 2004 | 279 | 0.010 |
Why?
| | Quality of Life | 1 | 2013 | 2892 | 0.010 |
Why?
| | Infant | 1 | 1995 | 9465 | 0.010 |
Why?
| | Probability | 1 | 2001 | 304 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 345 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2001 | 431 | 0.010 |
Why?
| | Bronchoscopy | 1 | 2001 | 223 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 2001 | 688 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2001 | 786 | 0.010 |
Why?
| | Glucan Endo-1,3-beta-D-Glucosidase | 1 | 1998 | 1 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 2001 | 1060 | 0.010 |
Why?
| | Pilot Projects | 1 | 2001 | 1710 | 0.010 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 1995 | 36 | 0.010 |
Why?
| | Bucladesine | 1 | 1995 | 26 | 0.010 |
Why?
| | Dactinomycin | 1 | 1995 | 28 | 0.010 |
Why?
| | Cycloheximide | 1 | 1995 | 55 | 0.010 |
Why?
| | Child | 2 | 2008 | 21935 | 0.010 |
Why?
| | Leukotriene C4 | 1 | 1993 | 11 | 0.010 |
Why?
| | Peritoneal Lavage | 1 | 1993 | 8 | 0.010 |
Why?
| | Diamide | 1 | 1993 | 5 | 0.010 |
Why?
| | Rosette Formation | 1 | 1993 | 16 | 0.010 |
Why?
| | Arachidonic Acid | 1 | 1993 | 120 | 0.010 |
Why?
| | Mice, Inbred DBA | 1 | 1993 | 200 | 0.010 |
Why?
| | DNA Primers | 1 | 1994 | 515 | 0.010 |
Why?
| | Epoprostenol | 1 | 1993 | 136 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2001 | 5131 | 0.010 |
Why?
| | Hematopoietic Stem Cells | 1 | 1993 | 406 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2001 | 10811 | 0.000 |
Why?
| | Mannans | 1 | 1986 | 6 | 0.000 |
Why?
| | Child, Preschool | 1 | 2001 | 11074 | 0.000 |
Why?
| | L-Lactate Dehydrogenase | 1 | 1986 | 122 | 0.000 |
Why?
|
|
Riches's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|